Sichuan Ruijian Medical's Beijing Exchange listing review suspended

PW Medtech Group Limited announced on September 30, 2025, that the review process for Sichuan Ruijian Medical's subsequent listing on the Beijing Stock Exchange has been suspended. The voluntary application for suspension was submitted by Sichuan Ruijian Medical on September 26, 2025, due to the upcoming expiration of financial statements dated December 31, 2024, included in its application documents. The Beijing Stock Exchange has since adjusted the review status to "suspension of review."

Despite the suspension, neither the subsequent listing nor its review process has been terminated. On the same day, Sichuan Ruijian Medical received the "Second Review Inquiry Letter on Sichuan Ruijian Medical Technology Co. Ltd.'s Application for Public Stock Issuance and Listing on the Beijing Stock Exchange." Trading of Sichuan Ruijian Medical shares on the NEEQs remains suspended as matters related to the listing are ongoing.

Shareholders and potential investors are advised that the subsequent listing is subject to market conditions and approvals from authorities, including the CSRC and the Beijing Stock Exchange. The company does not guarantee the listing will materialize or its timing, urging caution when dealing in the company's securities.